Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1
Terminated1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03095248Phase 2Terminated
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
EpendymomaGliomaMeningioma+2 more
StudychairStart date: 2017-05-08
NCT03101813Recruiting
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaDiffuse Midline Glioma, H3 K27M-Mutant
PrincipalinvestigatorStart date: 2012-06-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lindsey Hoffman, DO

Phoenix Children's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaDiffuse Midline Glioma, H3 K27M-Mutant

Worked with same sponsors:

Children's Hospital Medical Center, CincinnatiThe DIPG Collaborative
Collaborated on 1 trial
Similarity Score34%

Sabine Mueller, MD, PhD, MAS

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-MutantGlioma+1 more
Similarity Score15%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaEpendymomaMeningioma
Similarity Score11%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

EpendymomaGliomaMeningioma
Similarity Score11%

yu shi, MD

Shengjing Hospital

Related
7 trials

Shared therapeutic areas:

GliomaMeningiomaNeuroma, Acoustic
Similarity Score11%

Jiayi Huang, M.D.

Washington University School of Medicine

Related
7 trials

Shared therapeutic areas:

GliomaMeningioma
Similarity Score8%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

Related
17 trials

Shared therapeutic areas:

GliomaNeuroma, Acoustic
Similarity Score8%

John W Glod, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaEpendymoma
Similarity Score8%

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

GliomaMeningioma
Similarity Score8%

Katherine E Warren, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

EpendymomaGlioma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03095248Phase 2StudyChair

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

EpendymomaGliomaMeningioma+2 more
Terminated
NCT03101813PrincipalInvestigator

International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository

Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaDiffuse Midline Glioma, H3 K27M-Mutant
Recruiting

All 2 trials loaded